TransCode Therapeutics (RNAZ)
(Delayed Data from NSDQ)
$1.34 USD
+0.22 (19.64%)
Updated Jun 6, 2024 04:00 PM ET
After-Market: $1.33 -0.01 (-0.75%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth B Momentum F VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 33% (83 out of 248)Zacks Sector Rank
Top 50% (8 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | NA | NA |
Current Quarter Estimate | NA | NA | NA |
Year Ago Quarter Estimate | NA | NA | NA |
Next Quarter Estimate | NA | NA | NA |
Next Year Estimate | NA | NA | NA |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 98.09 | 14.30 | 15.67 |
Next Year | 66.16 | 14.90 | 9.31 |
Last 5 Years | NA | 6.90 | 8.10 |
Next 5 Years | NA | 24.00 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | NA |
Price/Book (MRQ) | NA | NA |
Price/Cash Flow (MRFY) | NA | NA |
Dividend Yield | NA | NA |
Net Profit Margin (TTM) | NA | NA |
Return on Equity (TTM) | NA | NA |
Debt to Equity (MRQ) | NA | NA |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.